We support you to access approved medicine that is not approved or available in your country of residence. Make an enquiry below to learn more.
Lucaftor (lumacaftor/ivacaftor) is a medicine indicated for the treatment of cystic fibrosis (CF) in patients 12 years and older who have two copies of the F508del mutation (F508del/F508del) in the CFTR gene.
Lucaftor (lumacaftor/ivacaftor) is a biosimilar of Orkambi (lumacaftor/ivacaftor). It has been approved by the National Administration of Drugs, Foods and Medical Devices (ANMAT), Argentina. We have it available to order as well. See [Orkambi (lumacaftor/ivacaftor)]
Medicine approved by
- Over 1.2 million patients reached
- Over 11,000 patients helped
- 13,000 medicines supplied
- 100% success delivering to people in 85 countries
Support with your prescription
The first thing we need is a prescription from your treating physician.
- Download our “Easy Prescription Guideline”
- Click on the “Make an enquiry” button to send us any questions you have or to upload your prescription if you already have one.
“I want to recommend everyone to work with this organization. They are reliable, honest, punctual and do everything to meet your needs…”
“Dr. Aysen Simsek and her team offered assistance during a very difficult time. I truly appreciate their quick, efficient and professional attitude, as well as their patience and superb customer service…”
“I highly recommend TheSocialMedwork. They welcomed me with open arms when I went to their office in Amsterdam. I was in a very difficult situation with a tight schedule, and their amazing team members…”
We are TheSocialMedwork, a registered medical intermediary that helps you access elsewhere approved medicines, no matter where you live. To date, we have assisted patients in over 80 countries to access thousands of life-improving medicines.Learn more
Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.